CS MEDICA Sign Contract with a Notified Body in Europe, Safeguarding Their Medical Device Product Line's Market Presence. CS MEDICA A/S is a first mover of CE-marked medical devices with CBD in the MDR (Medical Device Regulation) transition grace period until 2028. The Company's competitive advantage has been strengthened as CS MEDICA now secured its position by being one of the first companies in the European Union to sign with a Notified Body, to fulfill the required steps under Rule 21 toward compliance with the new regulations.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.657 DKK | -2.35% | +7.53% | +42.15% |
Apr. 22 | CS Medica A/S Advances Global Reach with 180° Drug Store Alliance, Powered by Pull Market Strategy | CI |
Apr. 12 | Transcript : CS Medica A/S, Q4 2023 Earnings Call, Apr 12, 2024 |
Annual profits - Rate of surprise
- Stock Market
- Equities
- CSMED Stock
- News CS MEDICA A/S
- CS Medica A/S Secures Future Compliance with New Medical Device Regulation Through Signed Contract with Notify Body